Rasburicase

FASTURTEC POWDER FOR SOLUTION FOR INFUSION 1.5 mg/vial

1.5 mg/vial injection, powder, for solutionSingaporeAuthorisedAuthorised 27 Aug 2002

In other countries

The same active substances on other registers, the same brand first.

FasturtecBrazil · Sanofi Medley Farmacêutica Ltda.Same brand
FasturtecBrazil · Sanofi - Synthelabo Farmacêutica LtdaSame brand
FasturtecBrazil · Sanofi-Aventis Farmacêutica LtdaSame brand
FasturtecCanada · 1.5 MG / VIAL · Powder For Solution · Sanofi-Aventis Canada INCSame brand
FasturtecCanada · 7.5 MG / VIAL · Powder For Solution · Sanofi-Aventis Canada INCSame brand
Fasturtec 1,5 MG/ML Polvo y Disolvente Para Concentrado Para Solucion Para PerfusionSpain · 1,5 mg · polvo y disolvente para concentrado para solución para perfusión · Sanofi Winthrop IndustrieSame brand
Fasturtec 1,5 MG/ML Polvo y Disolvente Para Concentrado Para Solucion Para Perfusion

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Rasburicase

FASTURTEC POWDER FOR SOLUTION FOR INFUSION 1.5 mg/vial

1.5 mg/vial injection, powder, for solutionSingaporeAuthorisedAuthorised 27 Aug 2002

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Spain · 7,5 mg · polvo y disolvente para concentrado para solución para perfusión · Sanofi Winthrop Industrie

FasturtecEuropean Union · Sanofi Winthrop Industrie

FasturtecCroatia

FasturtecItaly · Polvere e solvente per soluzione per infusione endovenosa · Sanofi Winthrop Industrie

Fasturtec 1,5 mg/ml poeder en oplosmiddel voor concentraat voor oplossing voor infusieNetherlands · Poeder en oplosmiddel voor concentraat voor oplossing voor infusie · Sanofi Winthrop Industrie

FasturtecSaudi Arabia · sanofi S.P.A

ElitekUnited States · 1.5MG/VIAL · vial · Sanofi Synthelabo

AnyNew Zealand · Inj 1.5 mg vial

ElitekUnited States · 7.5MG · For Injection · Sanofi-Aventis U.S. LLC

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Sciences Authority / data.gov.sg

Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence

Licence: Singapore Open Data Licence 1.0 · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Rasburicase
Strength: 1.5 mg/vial
Dosage form: injection, powder, for solution
Route: intravenous
Register: Singapore (HSA)
Status: Authorised
Status in the register: Registered
Authorised: 27 Aug 2002
Registration: SIN12055P
Marketing authorisation holder: Sanofi-Aventis Singapore Pte. LTD.
Manufacturer: SANOFI WINTHROP INDUSTRIE (Solvent manufacturer) / Sanofi S.r.l. (Powder and Solvent manufaturer), FRANCE / ITALY
ATC code: V03AF07
Group: Various
Supply: Prescription Only